Loading...
Safety and tolerability of once‐weekly GLP‐1 receptor agonists in type 2 diabetes
WHAT IS KNOWN AND OBJECTIVE: In recent years, glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) including once‐weekly (QW) formulations have been incorporated into type 2 diabetes (T2D) clinical guidelines, making it essential that pharmacists and healthcare professionals (HCPs) have a clear und...
Na minha lista:
| Udgivet i: | J Clin Pharm Ther |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7540535/ https://ncbi.nlm.nih.gov/pubmed/32910487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.13225 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|